Emerging frontiers in epigenetic-targeted therapeutics for pediatric neuroblastoma
Neuroblastoma (NB), the most prevalent extracranial solid malignancy in children, poses significant therapeutic challenges, particularly concerning high-risk subtypes characterized by an immunologically “cold” phenotype. These tumors evade immune surveillance through mechanisms such as impaired anti...
Saved in:
| Main Authors: | Xiaokang Wang, Gengrui Xu, Hongyan Ma, Xiaoyan Deng, Guiping Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1637626/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01) -
Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma
by: Albatool AlKhazal, et al.
Published: (2025-03-01) -
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
by: Roberta Veglia Tranchese, et al.
Published: (2024-11-01) -
Identification and verification of international neuroblastoma staging system (INSS) stage-related genes as potential biomarkers for neuroblastoma prognostic models
by: Can Qi, et al.
Published: (2025-04-01) -
Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study
by: Karina Viani, et al.
Published: (2024-12-01)